Centro Cardiologico Monzino

Milan 20154

4 studies enrolling now · 32 studies all time

What they study most

Acute Coronary Syndrome, Aortic Stenosis, Aortic Valve Disease, Arrhythmogenic Right Ventricular Cardiomyopathy, Atherosclerosis, Atherosclerotic Cardiovascular Disease (ASCVD), Atrial Fibrillation, Bradycardia, Cardiac Pacemaker, Artificial, Cardiac Rhythm Disorder, Cardiovascular Diseases, Cardiovascular Risk

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy — Recruiting now
• MYTHS - MYocarditis THerapy With Steroids — Recruiting now
• Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination — Paused
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Aveir DR i2i Study — Completed
• The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System — Completed
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — Completed
• Micra AV Transcatheter Pacing System Post-Approval Registry — Completed
• A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
• Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes — Completed
• Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation — Completed
• The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts) — Completed
• Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
• MitraClip EXPAND G4 Study — Running, not enrolling
• FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study — Completed
• Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System — Running, not enrolling
• Sorin Universal REgistry on Aortic Valve Replacement — Stopped early
• TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation — Completed
• The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Completed
• Fast Assessment of STenosis Severity- FASTII Study — Completed
• Observational Study of OCT in a Patients Undergoing FFR — Completed
• PRESSUREwire Study — Completed
• Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) — Completed
• EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed
• Electrophysiologic and Morphologic Assessment of the Substrate to Guide Implantation of Defibrillators in Dilated Cardiomyopathy — Status unconfirmed